BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15868412)

  • 1. Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase.
    Li X; Wang G; Zhao J; Ding H; Cunningham C; Chen F; Flynn DC; Reed E; Li QQ
    Cell Mol Life Sci; 2005 Apr; 62(7-8):894-904. PubMed ID: 15868412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
    Wang G; Li X; Huang F; Zhao J; Ding H; Cunningham C; Coad JE; Flynn DC; Reed E; Li QQ
    Cell Mol Life Sci; 2005 Apr; 62(7-8):881-93. PubMed ID: 15868411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs.
    Li QQ; Wang G; Huang F; Li JM; Cuff CF; Reed E
    Med Oncol; 2013 Mar; 30(1):488. PubMed ID: 23397083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.
    Lee RX; Li QQ; Reed E
    Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.
    Jin S; Tong T; Fan W; Fan F; Antinore MJ; Zhu X; Mazzacurati L; Li X; Petrik KL; Rajasekaran B; Wu M; Zhan Q
    Oncogene; 2002 Dec; 21(57):8696-704. PubMed ID: 12483522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
    Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
    Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ATF
    Zhai B; Chen P; Wang W; Liu S; Feng J; Duan T; Xiang Y; Zhang R; Zhang M; Han X; Chen X; Li Q; Li G; Liu Y; Huang X; Zhang W; Pan T; Yan L; Jin T; Xie T; Sui X
    Cancer Biol Med; 2020 Aug; 17(3):676-692. PubMed ID: 32944399
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells.
    Li QQ; Lee RX; Liang H; Zhong Y; Reed E
    Med Oncol; 2013 Mar; 30(1):424. PubMed ID: 23277286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synergistic effect of beta-elemene injection combined paclitaxel injection on human breast cancer MB-468 cells: an in vitro study].
    Cai DY; Gao X; Wu XH; Hong TT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jul; 33(7):978-82. PubMed ID: 24063225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
    Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
    Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells.
    Winters ZE; Ongkeko WM; Harris AL; Norbury CJ
    Oncogene; 1998 Aug; 17(6):673-84. PubMed ID: 9715268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.
    Horibe S; Matsuda A; Tanahashi T; Inoue J; Kawauchi S; Mizuno S; Ueno M; Takahashi K; Maeda Y; Maegouchi T; Murakami Y; Yumoto R; Nagai J; Takano M
    Life Sci; 2015 Mar; 124():31-40. PubMed ID: 25625243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT; Huang KY; Lin HY; Chung JG
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
    Wang M; Ma X; Wang J; Wang L; Wang Y
    Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.
    Yazlovitskaya EM; Persons DL
    Anticancer Res; 2003; 23(3B):2275-9. PubMed ID: 12894503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.
    Li QQ; Wang G; Liang H; Li JM; Huang F; Agarwal PK; Zhong Y; Reed E
    Anticancer Res; 2013 Apr; 33(4):1421-8. PubMed ID: 23564782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH; el-Naggar AK; Priebe W; Perez-Soler R
    Mol Pharmacol; 1996 May; 49(5):832-41. PubMed ID: 8622633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells.
    Cho JH; Lee JG; Yang YI; Kim JH; Ahn JH; Baek NI; Lee KT; Choi JH
    Food Chem Toxicol; 2011 Aug; 49(8):1737-44. PubMed ID: 21554918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.